SCOPUS 정보 검색 플랫폼

Volumn 343, Issue 23, 2000, Pages 1673-1680

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

(12) Heathcote, E Jenny a Shiffman, Mitchell L b Cooksley, W Graham E c Dusheiko, Geoffrey M d Lee, Samuel S e Balart, Luis f Reindollar, Robert g Reddy, Rajender K h Wright, Teresa L i Lin, Amy j Hoffman, Joseph j De Pamphilis, Jean j

a TORONTO WESTERN HOSPITAL (Canada)

b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE (United States)

c ROYAL BRISBANE AND WOMEN'S HOSPITAL (Australia)

d ROYAL FREE HOSPITAL (United Kingdom)

e ALBERTA ENVIRONMENT AND PARKS (Canada)

f LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE (United States)

g Carolinas Center for Liver Disease (United States)

h UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE (United States)

i SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; PEGINTERFERON ALPHA2A; RECOMBINANT ALPHA2A INTERFERON; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; FEVER; HEADACHE; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RIGOR; VIRUS LOAD;

EID: 0034619980 PISSN: 00284793 EISSN: None Source Type: Journal
DOI: 10.1056/NEJM200012073432302 Document Type: Article

Times cited : (882)

References (20)

1
- 0031308570
- Treatment of cirrhotic hepatitis C virus patients with daily doses of interferon-α2a
- (1997) J Viral Hepat , vol.4 , Issue.SUPPL. 2 , pp. 75-78
- Cooksley, W.G.E.¹ Dudley, F.J.² Watson, K.³

2
- 0032585237
- Randomised trial of interferon α2t plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
- (1998) Lancet , vol.352 , pp. 1426-1432
- Poynard, T.¹ Marcellln, P.² Lee, S.S.³

3
- 0032547938
- Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
- (1998) N Engl J Med , vol.339 , pp. 1485-1492
- McHutchison, J.G.¹ Gordon, S.C.² Schiff, E.R.³

4
- 0031796038
- Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: Perspective randomized multicentre study
- (1998) Ital J Gastroenterol Hepatol , vol.30 , pp. 517-523
- Ascione, A.¹ De Luca, M.² Canestrini, C.³

5
- 0032432551
- Is antiviral treatment (IFN alpha and/or ribavirin) justified in cirrhosis related to hepatitis C virus?
- (1998) Acta Gastroenterol Belg , vol.61 , pp. 431-437
- Poynard, T.¹ Moussali, J.² Ratziu, V.³

6
- 0032801727
- Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials
- (1999) Gastroenterology , vol.117 , pp. 408-413
- Schalm, S.W.¹ Wetland, O.² Hansen, B.E.³

7
- 0032997086
- Treatment of hepatitis C virus-related cirrhosis: A randomized, controlled trial of interferon alfa-2b versus no treatment
- (1999) Hepatology , vol.29 , pp. 1870-1875
- Valla, D.C.¹ Chevallier, M.² Marcellin, P.³

8
- 0032898286
- Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNA
- (1999) Hepatology , vol.29 , pp. 1573-1580
- Shiratori, Y.¹ Yokosuka, O.² Nakata, R.³

9
- 0001369293
- Single-dose safety/tolerability and pharmacokinetic/pharmacodynamics (PK/PD) following administration of ascending subcutaneous doses of pegylated-interferon (PEG-IFN) and interferon α-2a (IFN α-2a) to healthy subjects
- abstract
- (1998) Hepatology , vol.28 , Issue.SUPPL.
- Xu, Z.-X.¹ Hoffman, J.² Patel, I.³ Joubert, P.⁴

10
- 0001299981
- A branched methoxy 40 kDa polyethylene glycol (PEG) moiety optimizes the pharmacokinetics (PK) of peginterferon α-2a (PEG-IFN) and may explain its enhanced efficacy in chronic hepatitis C (CHC)
- abstract
- (1999) Hepatology , vol.30 , Issue.SUPPL.
- Algranati, N.E.¹ Sy, S.² Modi, M.³

11
- 0000211888
- A controlled, randomized, multicenter, descending dose phase II trial of pegylated interferon alfa-2a (PEG) vs standard interferon alfa-2a (IFN) for treatment of chronic hepatitis C
- abstract
- (1999) Gastroenterology , vol.116
- Shiffman, M.¹ Pockros, P.J.² Reddy, R.K.³

12
- 0034619946
- Peginterferon alfa-2a in patients with chronic hepatitis C
- (2000) N Engl J Med , vol.343 , pp. 1666-1672
- Zeuzem, S.¹ Feinman, S.V.² Rasenack, J.³

13
- 84984533465
- Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C
- (1996) Gastroenterology , vol.111 , pp. 1307-1312
- Lai, M.Y.¹ Kao, J.H.² Yang, P.M.³

14
- 0032499540
- International Conference on Harmonization: Draft guidance on specifications, test procedures, and acceptance criteria for biotechnological/biological products - FDA notice
- (1998) Fed Regist , vol.63 , pp. 31506-31513

15
- 0032796827
- Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test
- (1999) J Clin Microbiol , vol.37 , pp. 2625-2630
- Germer, J.J.¹ Rys, P.N.² Thorvilson, J.N.³ Persing, D.H.⁴

16
- 0019813866
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
- (1981) Hepatology , vol.1 , pp. 431-435
- Knodell, R.G.¹ Ishak, K.G.² Black, W.C.³

17
- 0032995997
- Efficacy of interferon treatment for patients with chronic hepatitis C: Comparison of response in cirrhotics, fibrotics, or nonfibrotics
- (1999) Hepatology , vol.30 , pp. 271-276
- Everson, G.T.¹ Jensen, D.M.² Craig, J.R.³

18
- 0031086205
- Interferon treatment of cirrhotic patients with chronic hepatitis C
- (1997) J Viral Hepat , vol.4 , pp. 81-91
- Idilman, R.¹ De Maria, N.² Colantoni, A.³ Dokmeci, A.⁴ Van Thiel, D.H.⁵

19
- 12644299637
- Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C
- (1997) Hepatology , vol.26 , pp. 780-785
- Shiffman, M.L.¹ Hofmarm, C.M.² Thompson, E.B.³

20
- 0000030258
- Combination therapy with peginterferon α-2a (PEG-IFN) and ribavirin in the treatment of patients with chronic hepatitis C (CHC): A phase II open-label study
- abstract
- (1999) Hepatology , vol.30 , Issue.SUPPL.
- Sulkowski, M.¹ Reindollar, R.² Yu, J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.